Follicular lymphoma is a slow-growing blood cancer that starts in B cells inside lymph nodes

Follicular lymphoma is a type of non-Hodgkin lymphoma that develops in the germinal centers of lymph nodes — the small bean-shaped organs that filter fluid and fight infection throughout your body. The cancer cells are B cells (a type of white blood cell) that have become abnormal and multiply uncontrollably, but they grow slowly compared to other lymphomas.

Most people with follicular lymphoma are diagnosed in their 60s or 70s, though it can occur at any age. It is one of the most common lymphomas in the United States, accounting for roughly one in five lymphoma cases. Because it grows slowly, many people live with it for years or even decades, sometimes without needing treatment right away.

Key Takeaways

  • Follicular lymphoma starts in B cells within lymph nodes and grows slowly, which means many people do not need immediate treatment after diagnosis.
  • Doctors identify it through a biopsy of an enlarged lymph node, followed by blood tests and imaging to see how far the cancer has spread.
  • The cancer is staged from 1 to 4 based on which lymph nodes and organs are involved, and this stage helps determine your treatment plan.
  • Treatment options include watchful waiting (monitoring without treatment), chemotherapy, targeted drugs, and radiation, depending on your stage and symptoms.
  • Follicular lymphoma often comes back after treatment, but people can live for many years with repeated rounds of therapy.

How follicular lymphoma develops and why it matters

Follicular lymphoma arises when B cells in the germinal centers of lymph nodes develop a genetic change that causes them to grow without the normal stop signals. This change usually involves a rearrangement of chromosomes called a translocation, where parts of two chromosomes swap places. The abnormal cells accumulate in the lymph node, causing it to swell.

The reason this cancer is called "follicular" is that it originates in the follicles — the germinal centers — of lymph nodes. Unlike aggressive lymphomas that spread quickly and cause obvious symptoms, follicular lymphoma often stays in the lymph nodes for a long time. Some people have no symptoms at all and discover it by chance during imaging for another reason.

One important feature of follicular lymphoma is that it can transform into a more aggressive form called diffuse large B-cell lymphoma (DLBCL). This happens in about 3 to 5 out of every 100 people with follicular lymphoma per year. When transformation occurs, the cancer grows much faster and requires more intensive treatment.

How doctors diagnose follicular lymphoma

Diagnosis begins when a doctor notices enlarged lymph nodes during an exam or on imaging done for another reason. To confirm follicular lymphoma, a doctor must perform a biopsy — removing a small sample of tissue from the enlarged lymph node and examining it under a microscope. A pathologist looks for the specific pattern of abnormal B cells that defines follicular lymphoma and may run additional tests to confirm the diagnosis.

After biopsy confirms the diagnosis, your doctor will order blood tests and imaging scans to determine how far the cancer has spread. Common imaging tests include a CT scan of the chest, abdomen, and pelvis, and sometimes a PET scan (positron emission tomography), which shows areas of high cell activity. Your doctor may also check your bone marrow with a biopsy to see whether cancer cells are present there.

Blood tests measure your complete blood count (the number of different types of blood cells) and check your liver and kidney function. Your doctor may also test for lactate dehydrogenase (LDH), an enzyme that can be elevated when lymphoma is active. These tests provide a baseline for comparison if you start treatment.

Staging: what it means and why doctors use it

Once your doctor has all the test results, they assign a stage from 1 to 4. Stage 1 means cancer is in one lymph node or one area of lymph nodes on one side of the diaphragm (the muscle that separates your chest from your abdomen). Stage 2 means cancer is in two or more lymph node areas on one side of the diaphragm. Stage 3 means cancer is in lymph nodes on both sides of the diaphragm. Stage 4 means cancer has spread to organs outside the lymph system, such as the liver, bone marrow, or lungs.

Your doctor may also add an "A" or "B" to your stage. "A" means you have no B symptoms — fever, night sweats, or unintended weight loss. "B" means you do have one or more of these symptoms, which can indicate more active disease.

Stage alone does not determine whether you need treatment right away. Many people with stage 3 or even stage 4 follicular lymphoma have no symptoms and can safely wait before starting therapy. Your doctor will consider your stage, symptoms, blood test results, and how fast the cancer appears to be growing when deciding on a treatment plan.

Treatment options for follicular lymphoma

Because follicular lymphoma grows slowly, many people do not need treatment immediately after diagnosis. Your doctor may recommend watchful waiting — regular monitoring with blood tests and imaging every few months to watch for signs that the cancer is becoming more active. You can start treatment later if symptoms develop or if tests show the cancer is growing faster.

When treatment is needed, options include chemotherapy (drugs that kill cancer cells), targeted therapies (drugs that attack specific features of cancer cells), monoclonal antibodies (proteins that mark cancer cells for destruction), and radiation therapy (high-energy beams aimed at specific lymph nodes). Many people receive a combination of these treatments.

One commonly used combination is called R-CHOP, which includes rituximab (a monoclonal antibody), cyclophosphamide, doxorubicin, vincristine, and prednisone. Another option is bendamustine plus rituximab. Your doctor will recommend a specific regimen based on your age, overall health, stage, and whether you have received treatment before.

Newer targeted drugs called BTK inhibitors (such as ibrutinib) and PI3K inhibitors (such as copanlisib) have shown promise in recent years and may be used alone or combined with other therapies. Your doctor can discuss which options are most appropriate for your situation.

What to expect during and after treatment

If you receive chemotherapy, treatment typically happens in cycles — you receive drugs over a period of days or weeks, then have a rest period to allow your body to recover. A full course of chemotherapy usually lasts several months. During treatment, you will have regular blood tests to monitor your blood cell counts and organ function, and imaging scans to see how the cancer is responding.

Side effects vary depending on the drugs used but may include nausea, fatigue, hair loss, increased infection risk, and mouth sores. Your doctor and nursing team can offer medications and strategies to manage these side effects. Most side effects improve or disappear after treatment ends, though some people experience long-term effects.

After treatment ends, you will continue to have follow-up appointments and imaging scans at regular intervals — often every few months at first, then less frequently as time goes on. Many people with follicular lymphoma go into remission (a period when the cancer cannot be detected), but the cancer often returns months or years later. When it does, you may receive treatment again, and many people respond well to repeated rounds of therapy.

Living with follicular lymphoma long-term

Follicular lymphoma is generally considered incurable with current treatments, but it is also often manageable over many years. People diagnosed with follicular lymphoma today have significantly longer survival times than those diagnosed decades ago, thanks to newer drugs and better understanding of the disease.

Your quality of life during and between treatments depends on many factors, including your age, overall health, and how your body responds to therapy. Some people have long periods of remission with no symptoms and no active treatment. Others need treatment more frequently. Your doctor can help you understand what to expect based on your individual situation.

Staying in close contact with your medical team, attending all follow-up appointments, and reporting new symptoms promptly helps catch any changes early. Many people with follicular lymphoma benefit from connecting with support groups or counseling, as living with a chronic cancer diagnosis can be emotionally challenging.

Frequently Asked Questions

Is follicular lymphoma the same as Hodgkin lymphoma?

No. Follicular lymphoma is a type of non-Hodgkin lymphoma, which is a different category. The main difference is where the cancer starts and which cells are involved. Hodgkin lymphoma has different cell types and a different pattern of spread. Treatment and outlook also differ between the two.

Can follicular lymphoma turn into a more serious cancer?

Yes, follicular lymphoma can transform into diffuse large B-cell lymphoma (DLBCL), a faster-growing form. This happens in a small percentage of people each year. If transformation occurs, your doctor will recommend more aggressive treatment. Your medical team monitors for signs of transformation during follow-up visits.

Do I need treatment right after diagnosis?

Not necessarily. Many people with follicular lymphoma have no symptoms and can safely wait before starting treatment. Your doctor will recommend watchful waiting with regular monitoring if your cancer is not causing problems. Treatment begins when symptoms develop or tests show the cancer is growing faster.

What is the difference between remission and cure?

Remission means the cancer cannot be detected on scans or blood tests, but it does not mean the cancer is gone forever. Follicular lymphoma often returns after remission, sometimes months or years later. Cure would mean the cancer never returns, which is rare with current treatments for follicular lymphoma.

Will I lose my hair during treatment?

Hair loss depends on which drugs you receive. Some chemotherapy drugs cause hair loss, while others do not. Targeted therapies and monoclonal antibodies typically do not cause hair loss. Your doctor can tell you what to expect with your specific treatment plan and discuss options like cold caps if hair loss is likely.